These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35701438)

  • 21. [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].
    Yu Q; Xiong X; Sun Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):1-19. PubMed ID: 32621419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting neddylation in cancer therapy.
    Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
    Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neddylation-cullin 2-RBX1 E3 ligase axis targets tumor suppressor RhoB for degradation in liver cancer.
    Xu J; Li L; Yu G; Ying W; Gao Q; Zhang W; Li X; Ding C; Jiang Y; Wei D; Duan S; Lei Q; Li P; Shi T; Qian X; Qin J; Jia L
    Mol Cell Proteomics; 2015 Mar; 14(3):499-509. PubMed ID: 25540389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.
    Yu Q; Hu Z; Shen Y; Jiang Y; Pan P; Hou T; Pan ZQ; Huang J; Sun Y
    Neoplasia; 2020 Apr; 22(4):179-191. PubMed ID: 32145688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repression of transcriptional activity of estrogen receptor alpha by a Cullin3/SPOP ubiquitin E3 ligase complex.
    Byun B; Jung Y
    Mol Cells; 2008 Apr; 25(2):289-93. PubMed ID: 18414007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of
    Yan M; Qi H; Li J; Ye G; Shao Y; Li T; Liu J; Piao HL; Xu G
    Oncotarget; 2017 Nov; 8(61):103032-103046. PubMed ID: 29262542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway.
    Han B; Sun Z; Yu T; Wang Y; Kuang L; Li T; Cai J; Cao Q; Xu Y; Gao B; Cheng SY; Yue S; Liu C
    Cell Death Discov; 2021 May; 7(1):120. PubMed ID: 34021128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diverse roles of SPOP in prostate cancer and kidney cancer.
    Wang Z; Song Y; Ye M; Dai X; Zhu X; Wei W
    Nat Rev Urol; 2020 Jun; 17(6):339-350. PubMed ID: 32355326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neddylation controls basal MKK7 kinase activity in breast cancer cells.
    Zhu T; Wang J; Pei Y; Wang Q; Wu Y; Qiu G; Zhang D; Lv M; Li W; Zhang J
    Oncogene; 2016 May; 35(20):2624-33. PubMed ID: 26364603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of high-order oligomerization of the cullin-3 adaptor SPOP.
    van Geersdaele LK; Stead MA; Harrison CM; Carr SB; Close HJ; Rosbrook GO; Connell SD; Wright SC
    Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1677-84. PubMed ID: 23999291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse and pivotal roles of neddylation in metabolism and immunity.
    Zou T; Zhang J
    FEBS J; 2021 Jul; 288(13):3884-3912. PubMed ID: 33025631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants.
    An J; Wang C; Deng Y; Yu L; Huang H
    Cell Rep; 2014 Feb; 6(4):657-69. PubMed ID: 24508459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.
    Xiang S; Shi X; Chen P; Chen Y; Bing S; Jin X; Cao J; Wang J; Yang B; Shao X; He Q; Ying M
    Pharmacol Res; 2021 Jul; 169():105616. PubMed ID: 33872809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions.
    Jiang Q; Zheng N; Bu L; Zhang X; Zhang X; Wu Y; Su Y; Wang L; Zhang X; Ren S; Dai X; Wu D; Xie W; Wei W; Zhu Y; Guo J
    Mol Cancer; 2021 Aug; 20(1):100. PubMed ID: 34353330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The E3 ligase C-CBL inhibits cancer cell migration by neddylating the proto-oncogene c-Src.
    Lee GW; Park JB; Park SY; Seo J; Shin SH; Park JW; Kim SJ; Watanabe M; Chun YS
    Oncogene; 2018 Oct; 37(41):5552-5568. PubMed ID: 29899407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells.
    Lan X; Khandros E; Huang P; Peslak SA; Bhardwaj SK; Grevet JD; Abdulmalik O; Wang H; Keller CA; Giardine B; Baeza J; Duffner ER; El Demerdash O; Wu XS; Vakoc CR; Garcia BA; Hardison RC; Shi J; Blobel GA
    Blood Adv; 2019 May; 3(10):1586-1597. PubMed ID: 31126914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
    Yu Q; Sun Y
    Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity.
    Zhou H; Lu J; Chinnaswamy K; Stuckey JA; Liu L; McEachern D; Yang CY; Bernard D; Shen H; Rui L; Sun Y; Wang S
    Nat Commun; 2021 May; 12(1):2621. PubMed ID: 33976147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
    Yan W; Shi X; Wang H; Liao A; Yang W
    J Transl Med; 2022 Jun; 20(1):296. PubMed ID: 35773729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Protein Neddylation for Cancer Therapy.
    Zhou L; Jia L
    Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.